DBVTDBV Technologies S.A.

Nasdaq dbv-technologies.com


$ 0.93 $ 0.00 (0 %)    

Monday, 26-Aug-2024 08:03:54 EDT
QQQ $ 479.76 $ 5.15 (1.08 %)
DIA $ 411.97 $ 4.35 (1.07 %)
SPY $ 562.55 $ -0.64 (-0.11 %)
TLT $ 98.37 $ 0.64 (0.65 %)
GLD $ 231.99 $ 2.65 (1.16 %)
$ 0.92
$ 0.93
$ 0.93 x 1,100
-- x --
$ 0.93 - $ 0.93
$ 0.50 - $ 3.70
5,753
na
88.78M
$ 1.06
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 07-30-2024 06-30-2024 10-Q
2 05-07-2024 03-31-2024 10-Q
3 03-07-2024 12-31-2023 10-K
4 10-31-2023 09-30-2023 10-Q
5 07-31-2023 06-30-2023 10-Q
6 05-04-2023 03-31-2023 10-Q
7 03-02-2023 12-31-2022 10-K
8 11-03-2022 09-30-2022 10-Q
9 08-01-2022 06-30-2022 10-Q
10 05-02-2022 03-31-2022 10-Q
11 03-09-2022 12-31-2021 10-K
12 10-26-2021 09-30-2021 10-Q
13 08-02-2021 06-30-2021 10-Q
14 05-05-2021 03-31-2021 10-Q
15 03-17-2021 12-31-2020 10-K
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 hc-wainwright--co-reiterates-buy-on-dbv-technologies-maintains-5-price-target

HC Wainwright & Co. analyst Andrew Fein reiterates DBV Technologies (NASDAQ:DBVT) with a Buy and maintains $5 price target.

 jmp-securities-maintains-market-outperform-on-dbv-technologies-raises-price-target-to-5

JMP Securities analyst Jonathan Wolleben maintains DBV Technologies (NASDAQ:DBVT) with a Market Outperform and raises the pr...

 dbv-technologies-faces-uncertainties-in-securing-necessary-financing-under-favorable-terms-due-to-potential-global-financial-disruptions-with-risks-exacerbated-by-economic-downturns-potentially-forcing-operational-scale-backs-or-unwanted-collaborative-financial-arrangements-without-adjustments-made-in-this-financial-statement-for-going-concern-uncertainties

The Company intends to seek additional capital as it continues research and development efforts and prepares for the launch of ...

 dbv-technologies-q2-eps-034-beats-045-estimate-sales-116m-miss-168m-estimate

DBV Technologies (NASDAQ:DBVT) reported quarterly losses of $(0.34) per share which beat the analyst consensus estimate of $(0....

 dbv-technologies-announces-plan-to-implement-ads-ratio-change-from-1-ads-to-12-of-a-ordinary-share-to-1-ads-to-1-ordinary-share-anticipates-that-the-ads-ratio-change-will-be-effective-on-or-about-june-7th-2024

DBV Technologies, a clinical-stage biopharmaceutical company focused on treatment options for food allergies and other immunolo...

 dbv-technologies-announces-plan-to-implement-ads-ratio-change-from-the-current-ads-ratio-of-1-ads-to-12-of-one-1-ordinary-share-to-a-new-ads-ratio-of-one-1-ads-to-1-ordinary-share

DBV Technologies Announces Plan to Implement ADS Ratio ChangeDBV Technologies (Euronext: DBV – ISIN: FR0010417345 – Nasdaq Stoc...

 hc-wainwright--co-maintains-buy-on-dbv-technologies-lowers-price-target-to-5

HC Wainwright & Co. analyst Andrew Fein maintains DBV Technologies (NASDAQ:DBVT) with a Buy and lowers the price target ...

 dbv-technologies-q1-eps-028-beats-021-estimate-sales-140m-miss-227m-estimate

DBV Technologies (NASDAQ:DBVT) reported quarterly earnings of $0.28 per share which beat the analyst consensus estimate of $(0....

 dbv-technologies-q4-2023-gaap-eps-0060-sales-8875m-beat-412000k-estimate

DBV Technologies (NASDAQ:DBVT) reported quarterly losses of $(0.060) per share. The company reported quarterly sales of $8.875...

 earnings-scheduled-for-march-7-2024

Companies Reporting Before The Bell • CI&T (NYSE:CINT) is estimated to report quarterly earnings at $0.06 per share on rev...

 hc-wainwright--co-reiterates-buy-on-dbv-technologies-maintains-10-price-target

HC Wainwright & Co. analyst Andrew Fein reiterates DBV Technologies (NASDAQ:DBVT) with a Buy and maintains $10 price tar...

 dbv-technologies-and-2-other-stocks-under-2-insiders-are-buying

The Dow Jones index closed higher by around 50 points on Thursday. When insiders purchase or sell shares, it indicates their co...

 top-5-health-care-stocks-that-could-blast-off-in-december

The most oversold stocks in the health care sector presents an opportunity to buy into undervalued companies.

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION